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Dendritic cells (DCs) initiate and maintain adaptive T helper 2 (Th2) cell responses to inhaled allergens in
asthma. Various functions like antigen uptake, migration to the draining LNs, and induction of tolerance
and adaptive immunity are not equally shared by all subsets of DCs, adding considerable complexity to
understanding the immunology of allergic sensitization. Whereas the epithelium was initially considered
solely as a physical barrier, it is now seen as a central player in controlling the function of lung DCs through
release of Th2 cell-promoting cytokines. Although DCs are sufficient and necessary for induction of Th2 cell
responses to many antigens, some allergens might require antigen presentation by basophils. Clinically rele-
vant allergens, as well as environmental and genetic risk factors for allergy and asthma, often interfere
directly or indirectly with the innate immune functions of airway epithelial cells, basophils, and DCs. This
review summarizes the recent progress on our understanding how DCs control Th2 cell immunity in the lung.Introduction: The Adaptive Immune Response
in Allergic Asthma
In allergic asthma, genetically susceptible individuals mount
a chronic Th2 cell-type of immune response to allergens like
house-dust mites (HDMs), molds, plant pollen, and animal
dander that is measured clinically by the presence of a serum
IgE response or the presence of a positive skin-prick test. Bron-
chial biopsy studies in human asthmatics have revealed
a predominant eosinophilic airway inflammation accompanied
by an accumulation at the airway wall of helper T cells. In initial
studies, it was found that CD4+ T cells in human asthmatics as
well as in mouse models of asthma secrete interleukin-4 (IL-4),
IL-5, IL-13, and tumor-necrosis factor (TNF)—a phenotype
consistent with inflammatory T helper 2 (Th2) cells (Robinson
et al., 1992). Studies in mouse models with blocking antibodies
or transgenic modeling have shown that individually, these cyto-
kines can already explain many of the salient features of asthma
such as IgE synthesis (IL-4 acting on B cells), airway eosinophilia
(IL-5 acting on bone marrow progenitors), goblet cell metaplasia
(IL-4 and IL-13 acting on epithelia), and bronchial hyperreactivity
(BHR) (IL-13 acting on bronchial smooth muscle cells) (Wills-
Karp et al., 1998). Increasingly, other Th cell subsets have
been linked to disease pathogenesis. The presence of IL-9 in
mouse and man is strongly associated with mast cell accumula-
tion in the airways, as well as BHR and mucus cell metaplasia,
although it remains to be established whether IL-9 derives from
a dedicated Th9 cell (Longphre et al., 1999). Closely related to
this Th9 cell subset, some patients with severe airway obstruc-
tion (often characterized by neutrophilic inflammation and
steroid resistance) might have a predominant Th17 cell compo-
nent (Traves and Donnelly, 2008; see article by Barrett and
Austen, 2009, in this issue of Immunity). Similarly, in almost
all patients with asthma, one can find a counterregulatory
population of allergen-specific Treg cells that downregulate
allergic inflammation through instruction by TGF-b and/or IL-10412 Immunity 31, September 18, 2009 ª2009 Elsevier Inc.(see article by Lloyd and Hawrylowicz, 2009, in this issue of
Immunity).
Dendritic Cells Bridge Innate and Adaptive Immunity
Many other factors such as respiratory virus infection, exposure
to airborne pollutants (tobacco smoke, diesel particles, and
ozone), or physical stimuli (exercise and cold air) can either
modify or exacerbate the disease (Cookson, 2004). Often these
exacerbating factors interfere with the innate immune system or
with the homeostasis of lung structural cells, so it is increasingly
appreciated that asthma is more than a disorder of the adaptive
immune response and is heavily influenced by pattern recogni-
tion by the innate immune cells such as bronchial epithelial cells,
mast cells and basophils, natural killer (NK) cells, and NKT cells.
Like in other epithelia and skin, the lung is equipped with an
elaborate network of dendritic cells (DCs) that can be found
throughout the conducting airways, lung interstitium, lung
vasculature, pleura, and bronchial lymph nodes (for recent
review see GeurtsvanKessel and Lambrecht, 2008). These cells
perform a unique sentinel function in the pulmonary immune
response in that they recognize inhaled antigens through expres-
sion of ancient pattern-recognition receptors such as Toll-like
receptors, NOD-like receptors, and C-type lectin receptors
that will recognize motifs on virtually any inhaled pathogen,
allergen, or substance (Barrett et al., 2009). Additionally, lung
DCs express numerous receptors for inflammatory mediators
that are released upon damage (so-called damage-associated
molecular patterns like uric acid, high mobility group box 1) to
the tissues by pathogens, trauma, vascular damage, or necrosis.
By exerting all these direct and indirect sensing mechanisms for
danger in the airways, and at the same time expressing all the
machinery to migrate to the regional lung-draining lymph nodes
and process antigens on their way to the node (Vermaelen et al.,
2001), DCs are at the nexus of innate and adaptive immunity in
the lung. In this review, we will discuss recent progress in the
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activated in response to allergens and contribute to allergic
disease by programming and maintaining adaptive immunity.
Most of the discussed data derive from studies in the mouse,
and where possible, parallels to the situation in human asthma
will be drawn.
The Increasing Complexity of Lung DC Subsets
Although lung DCs were originally described in the mouse as
a single population of highly dendritic-shaped cells with high
degree of expression of CD11c and MHCII (Sertl et al., 1986), it
is now clear that at least five different subsets of DCs can be
found in the lungs (see Figure 1). Most importantly, there is divi-
sion of labor between these various lung DC subsets, making
a closer distinction into subsets almost imperative if one is to
understand the biology of lung DCs (GeurtsvanKessel and Lam-
brecht, 2008). The mouse lung is grossly divided into large con-
ducting airways and lung interstitium containing alveloar septa
and capillaries where gas exchange is taking place (Wikstrom
and Stumbles, 2007). In steady-state conditions, the conducting
airways of all species studied are lined with an intraepithelial
highly dendritic network of MHCIIhiCD11chi cells that are mostly
CD11b and at least in the mouse and rat express langerin and
the mucosal integrin CD103 (aEb7), and in addition has the
propensity of extending dendrites into the airway lumen through
formation of tight junctions with bronchial epithelial cells (Geurts-
vanKessel et al., 2008; Jahnsen et al., 2006; Lambrecht et al.,
1998; Sung et al., 2006). Immediately below, the lamina propria
of the conducting airways contains MHCIIhiCD11chi cells that
are highly expressing CD11b and are a rich source of proinflam-
matory chemokines (Sung et al., 2006; van Rijt et al., 2005). The
CD11b+CD103 subset also expresses the SIRPa molecule,
a binding partner to CD47 involved in DC migration (Raymond
et al., 2009). A similar broad division into CD11b+ and CD11b
can also be applied to lung interstitial DCs obtained by enzy-
matic digestion of peripheral distal lung (GeurtsvanKessel
et al., 2008; von Garnier et al., 2005). Both CD11b+ and
CD11b subsets express high amounts of CD11c, so they can
best be denominated as conventional DCs (cDCs), to contrast
this with another population of CD11cint plasmacytoid DCs
(pDCs) that express Siglec-H, and the bone-marrow stromal
antigen-1, and some markers shared with granulocytes and
B cells (Figure 1; De Heer et al., 2004; GeurtsvanKessel et al.,
2008; Kool et al., 2009). The exact anatomical location of lung
pDCs is unclear although they can be found to line alveolar septa
in situ and have been recovered from digests of large conducting
airways (De Heer et al., 2004; Wikstrom and Stumbles, 2007).
The alveolar space also contains CD11chiMHCIIhi DCs and is
easily accessible by bronchoalveolar lavage. At least in the rat
and man, alveolar DCs are highly enriched in CD103+ subsets
that resemble Langerhans cells in man. One caveat is, however,
that lung alveolar macrophages express high amounts of CD11c
while lacking CD11b, essentially confusing many analyses of
lung DC biology if one does not use autofluorescence to identify
macrophages (Vermaelen and Pauwels, 2004). Under inflamma-
tory conditions, such as viral infection, allergen challenge, or LPS
administration, there is recruitment of additional subsets of
CD11b+ monocyte-derived DCs that rapidly upregulate CD11c
and retain expression of Ly6C as a remnant of their monocyticdescent, and are easily confused with resident CD11b+ cDCs
(GeurtsvanKessel et al., 2008; Hammad et al., 2009; Jakubzick
et al., 2008a).
Origin of Lung DC Subsets
Much progress has been made recently on the identification of
the precise progenitor for DCs that reside in the central lymphoid
organs. In a series of adoptive transfer studies, as well as Lyso-
syme (Lys)MCre-mediated lineage tracing of monocyte-derived
cells, it was elegantly shown that the majority of lung-resident
cDCs do not derive from the same Flt3+ progenitor that seeds
the central lymphoid organs, but rather originate from circulating
blood monocytes (Jakubzick et al., 2008a, 2008b; Varol et al.,
2007). A population of Ly-6ChiCCR2hiCX3CR1
int monocytes is
characterized as the more classical monocytes that readily
emigrate to sites of ongoing inflammation, whereas Ly-
6CloCCR2lo monocytes expressing high levels of the fractalkine
receptor CX3CR1 do not robustly emigrate to many tissues,
but do migrate well to lung even in absence of inflammation
(Landsman et al., 2007). It was suggested that under homeo-
static conditions, CD103+CD11b DCs preferentially derived
from CCR2hi monocytes, whereas CD11bhi cDCs preferentially
arise from CCR2lo monocytes, thus lending proof to the concept
that subsets of monocytes recruited to the same tissue undergo
differential differentiation pathways within the DC lineage



























Figure 1. Lung Dendritic Cell Subsets
In steady-state conditions (depicted on the left), conventional DCs (subdivided
into CD11b+ and CD11b subsets) line the conducting airways. They can also
be found back in the deeper interstitial compartments, obtained by enzymatic
digestion of peripheral lung. Plasmacytoid DCs are also found in both
compartments with a slight preference for the interstitial compartment. Finally,
the alveolar space contains DCs that can be easily confused with alveolar
macrophages if one does not take autofluorescence of the latter into account.
Under inflammatory conditions, there is recruitment of CD11b+ monocytes to
the lungs and these rapidly becomeDCs. They can still express Ly6C as part of
their monocytic descent. In viral infection as well as in some cancers, there is
also recruitment of interferon-producing killer DCs, a subset of NK cells that
can be mistaken for pDCs in view of their intermediate expression of CD11c
and expression of the B cell marker B220. One way of discriminating these
is via staining for NK1.1.Immunity 31, September 18, 2009 ª2009 Elsevier Inc. 413
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has only partially been addressed, nor is it clear at present
whether DCs at various anatomical compartments all depend
on monocytic precursors or more committed Flt3+ DC precur-
sors. One report has studied the phenotype and distribution of
lung DCs in Flt3L-deficient mice. Although these mice have
a dramatic reduction in cDCs and pDCs in central lymphoid
organs, there was virtually no reduction in conducting airway
cDCs. Strikingly, however, lung DCs obtained by enzymatic
digestion of peripheral lung were severly reduced (>95%) in
these mice (Walzer et al., 2005). These data imply that peripheral
lung DCs derive from a different Flt3-dependent progenitor than
do mucosal cDCs. The small population of lung pDCs seems to
derive from a Flt3+ cDC progenitor, because administration of
recombinant Flt3L to the lungs of mice leads to a large increase
in these cells, in addition to amore immature cDC-like population
(Kool et al., 2009; Shao et al., 2009).
Sentinel Function of Lung DCs Requires Instruction
by Epithelial Cells
Seminal studies by Holt have revealed that conducting airway
DCs have a rapid half-life of about 2 days, whereas more distal
lung DCs have a slower turnover rate (Holt et al., 1994). By
analogy with the gut mucosal immune system, where intestinal
mucosa-derived DCs were found to migrate into afferent
lymphatics even in the steady state, it was assumed that the con-
ducting airway DC compartment was turning over so rapidly
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Figure 2. Interactions between Epithelial
Cells and Dendritic Cells in the Airways
Dendritic cells (DCs) sample the airway lumen by
forming dendritic extensions in between epithelial
cells. The cells form tight junctions with epithelial
cells by expressing occludin and claudin family
members as well as zona occludens-1 (ZO-1). In
addition, the cells attach to airway epithelial cells
via E-cadherin and CD103 expressed by a subset
of DCs that probes the airway lumen. Enzymati-
cally active allergens can activate protease-acti-
vated receptors (PARs) expressed by epithelial
cells followed by nuclear factor-kB (NF-kB) activa-
tion and the production of chemokines and cyto-
kines by epithelial cells that attract and activate
DCs. Allergens often contain Toll-like receptor
(TLR) agonists and C type lectin agonists and trig-
gering through these also induces NF-kB activa-
tion and DC activation either directly or indirectly
via effects on epithelial cells that also express
TLRs and C-type lectin receptors.
mediastinal lymph nodes, even in the
absence of overt insults to the lung. This
was only an assumption and hard to
reconcile with the fact that the gut is
heavily colonized by microbes, whereas
the (deeper) lung of unmanipulated
animals is a relatively sterile environment.
These studies were, however, supported
by follow-up studies in which large fluo-
rescent yet innocuous tracer molecules
like FITC-dextran or FITC-OVA were
seen to be taken by lung DCs to the mediastinal nodes in
steady-state conditions, in a CCR7-dependent manner (De
Heer et al., 2004; del Rio et al., 2007; Vermaelen et al., 2001).
None of these studies have, however, eliminated completely
the possibility that these findings were caused by manipulations
in the mouse or that the fluorescent tracers were contaminated
with low amounts of TLR agonists. In a very elegant study,
Jakubzick et al. (2008a) have used a genetic tagging technique
employing LysMCre crossed to ROSA26 stop-flox GFP mice to
study lung DC migration behavior during true homeostasis in
the lung. They essentially found that without some form of TLR
stimulation, very little if any mediastinal LN DCs were derived
from LysMCre-tagged monocyte-derived cDCs in the lung,
essentially questioning the paradigm of steady-state sampling
and migration by mucosal lung DCs (Jakubzick et al., 2008a).
It follows that most of the lung DCmigration to theMLN results
from some form of insult to the lung, be it microbial, physical, or
toxic in nature. Based on the anatomical distribution of even the
most exposed DCs, it is immediately clear that DCs are basically
always covered by a layer of epithelial cells that seals off the
inhaled air by formation of tight junctions (see Figure 2). It is
therefore possible that in the absence of any TLR or other acti-
vating signals, the DCs do not extend dendrites across this
epithelial barrier. We recently hypothesized that airway epithelial
cells might be instructive in causing DC sentinel behavior and
activation in the lungs (Hammad and Lambrecht, 2008). By using
a series of radiation chimeric mice in which either radioresistant
stromal cells or radiosensitive hematopoietic cells were deficient414 Immunity 31, September 18, 2009 ª2009 Elsevier Inc.
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dynamic scanning behavior of lung DCs as well as their directed
migration to the mediastinal nodes in response to LPS inhalation
was largely dependent on TLR4 signaling on epithelial cells
(Hammad et al., 2009). A similar situation occurred in intestinal
jejunum epithelium where TLR triggering of epithelial cells in
response to invasive and noninvasive microbes also leads to
a ‘‘periscope-up’’ function of mucosal DCs (Chieppa et al.,
2006). This situation bywhich stromal cells instruct the functional
behavior of DCs seems to be quite specific to the mucosal envi-
ronment, as shown by the fact that Nolte et al. (2007) who used
a similar radiation chimeric approach found no evidence for
stromal instruction of splenic DCs to systemically administered
antigens. Which epithelial signals program this scanning
response is largely unknown, but one possibility is the regulated
expression or display of chemokines along the extracellular
matrix of epithelial cells, followed by the secretion of DC-acti-
vating cytokines (see below).
Allergic Sensitization Results from Activation
of the Epithelial-DC Crosstalk
It is immediately clear from analysis of the common characteris-
tics of clinically relevant allergens that most have the potential to
modify epithelial barrier function or activate airway epithelial cells
or innate and adaptive immune cells, like DCs and basophils
(summarized in Hammad and Lambrecht, 2008). For example,
house dust mite (Dermatophagoides pteronyssinus) fecal pellets
contain many allergens (Derp1 to -9) that have either proteolytic
activity or enhance TLR responsiveness, explaining why HDM
acts as an allergen and a Th2 cell adjuvant. Derp1 allergen,
a major allergen of the HDM, increases the permeability of the
bronchial epithelium, as measured by a decrease in transepithe-
lial electrical resistance by cleaving the tight junctional proteins
claudin and occludin, thus gaining access to the DC network
(Wan et al., 1999). In addition to these proteolytic effects of
HDM, b-glucan-rich motifs of HDM were able to trigger human
bronchial epithelial cells most likely via the dectin-1 receptor
and downstream Syk signaling to produce CCL20, a major che-
mokine causing attraction of lung DCs (see Figure 2; Nathan
et al., 2009). Along the same line, TLR4 signaling is also involved
in recognition of HDM allergen (Phipps et al., 2009). In an elegant
study, Trompette et al. recently demonstrated that Derp2 is
a functional homolog of the adaptor MD-2 (also known as
LY96), the LPS-binding component of the TLR-4 signaling
complex in this way stabilizing TLR4 expression on bronchial
epithelial cells (Trompette et al., 2009). In the same setting of
TLR4 radiation chimerics, we have shown that it is mainly the
epithelial TLR4-driven response that activates Th2 cell immunity
to HDM allergen, through release of innate pro-Th2 cytokines,
like GM-CSF, IL-33, TSLP, and IL-25 (see Figures 2 and 3; Ham-
mad et al., 2009). The TLR-, C-type lectin-, or proteolytic-medi-
ated activation of epithelial cells by HDM can lead to release of
these innate cytokines or other mediators that subsequently
program DCs to become Th2 cell inducers (Hammad et al.,
2009). GM-CSF promotes DC maturation and breaks inhalation
tolerance, and previous studies demonstrated that HDM-driven
asthma is neutralized by blocking GM-CSF (Cates et al., 2004).
Interleukin-33 is made by epithelial cells, boosts Th2 cytokine
production, and promotes goblet cell hyperplasia. It was recentlyshown to also promote Th2 cell differentiation by programming
the function of DCs (Rank et al., 2009).
Thymic Stromal Lymphopoietin, a UniqueDC-Instructive
Signal
TSLP is a 140 amino acid IL-7-like 4-helix-bundle cytokine that
has potent DC-modulating capacities, by binding its receptor
complex, composed of the IL-7 receptor (IL-7R) and the TSLP
receptor (TSLPR) (Liu et al., 2007). TSLP can directly activate
DCs to prime naive CD4+ T cells to differentiate into proinflam-
matory Th2 cells that secrete IL4, IL-5, IL-13, and TNF-a, but
not IL-10, and express the prostaglandin D2 receptor CRTH2
(chemoattractant receptor-homologous molecule expressed
on Th2 cells), a T cell phenotype that is also found in asthmatic
airways (Ito et al., 2005). The way by which this polarization
occurs has been studied in detail and involves the induction of
the Th2 cell-prone costimulatory molecule OX40L and their
production of the Th2 cell-attractive chemokines CCL17 and
CCL22 by DCs (see Figure 2; Ito et al., 2005). In addition, TSLP
might promote the production of Th2 cytokines by lymphocytes
directly. The polarization of Th2 cells induced by TSLP-matured
DCs is further enhanced by IL-25, which is produced by epithelial
cells, basophils, and eosinophils (Wang et al., 2007). Several
reports showed that airway epithelial cells can produce IL-25
in response to an innate immune response to allergen, a process
requiring epithelial cleaving of IL-25 by matrix metalloproteinase
7 (see Figure 2; Angkasekwinai et al., 2007; Goswami et al., 2009;
Hammad et al., 2009). In addition to its effects on DCs, TSLP can
also activate human mast cells to produce Th2 cell-associated
effector cytokines in the absence of T cells or IgE crosslinking
(Allakhverdi et al., 2007).
The most convincing evidence for a role for TSLP in DC-
driven Th2-cell development came from studies in mice that
conditionally overexpressed TSLP in the lungs. These mice
mounted a vigorous DC-driven primary Th2 cell response to
environmental antigens in the airways (Headley et al., 2009;
Zhou et al., 2005). By contrast, Tlspr/ mice fail to develop
an antigen-specific Th2 cell inflammatory response in the
airways unless they are supplemented with wild-type CD4+
T cells (Al-Shami et al., 2005). Taken together, these data
suggest that TSLP produced by the lung epithelium might repre-
sent a crucial factor that can initiate allergic responses at the
epithelial cell surface. Therefore, it will be very important to
study how the production of TSLP by epithelial cells and other
inflammatory cells is regulated. Strikingly, IL-13 was shown to
induce expression of TSLP, pointing out to an important feed-
back-loop acting via DCs to enhance Th2 cell immunity (Miyata
et al., 2009).
Direct Effects of Allergens on DCs
The indirect activation events through airway epithelial cells do
not exclude direct effects of allergens on lung DCs. The proteo-
lytic activity of Derp1 has long been known to activate human
monocyte-derived cDCs and pDCs to promote Th2 cell
responses through effects on polarizing cytokines, costimulatory
molecules, and cell surface receptors (Charbonnier et al., 2003;
Hammad et al., 2001, 2003b). In the mouse, Barrett et al. (2009)
recently described a dectin-2-mediated recognition of HDM by
bone-marrow-derived DCs that led to spleen tyrosine kinase
(Syk)-dependent synthesis of cysteinyl leukotrienes, possibly
explaining some of the proallergic effects of HDM.Immunity 31, September 18, 2009 ª2009 Elsevier Inc. 415
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Although here we focused mainly on HDM as a relevant allergen,
many other allergens have similar effects on either epithelial
barrier, epithelial activation, or direct DC activation (summarized
in Hammad and Lambrecht, 2008). Likewise, most known envi-
ronmental risk factors that are associated with development of
allergy like cigarette smoking, exposure to ambient particulate
matter like diesel exhaust, exposure to high ozone concentra-
tions, or exposure to RSV virus have the potential to interfere
with the epithelial-DC crosstalk. Cigarette smoking enhances
epithelial permeability and induces the production of TSLP by
airway epithelial cells (reviewed in Robays et al., 2009; Monick
et al., 2003), whereas the Th2 cell adjuvant effects of diesel
depend on epithelial production of GM-CSF (Bleck et al., 2006).
RSV infection leads to direct DC activation but also leads to
persistent upregulation of the MD-2 molecule on epithelial cells,
explaining why children might be hypersensitive to subsequent


























Figure 3. Early Innate Cytokine Responses
that Promote Allergic Inflammation
Allergen stimulation of protease-activated
receptor 2 (PAR2), C-type lectin receptors, or
Toll-like receptors (TLRs) triggers the production
of thymic stromal lymphopoeitin (TSLP), gran-
ulocyte-macrophage colony stimulating factor
(GM-CSF), and IL-33by airway epithelial cells. TSLP
induces immediate innate immune functions in
DCs leading to chemokine-driven recruitment of
Th2 cells and eosinophils to the airways. Epithelial
cells produce CCL20 in a process involving TRAIL
and IL-25 in a process requiring MMP7. The
effects of CCL20 and IL-25 are to further attract
innate immune cells and Th2 cells to the lungs.
TSLP and IL-33 stimulate the functions of mast
cells and basophils. TSLP and IL-33 also induce
DCs to migrate to the mediastinal lymph nodes
and induce the polarization of inflammatory Th2
cells in an OX40L-dependent fashion. In contrast
to most other triggers that induce DC maturation,
TSLP-induced maturation is not accompanied by
the production of interleukin-12 (IL-12), thereby
explaining Th2 cell polarization. Mast cells and
basophils can also serve an important role for
providing an early source of IL-4 for Th2 cell devel-
opment. Basophils are recruited to draining lymph
nodes in a process requiring TSLP. Together with
mediators released by mast cells and basophils,
effector Th2 cells control the salient features of
asthma.
Epithelial-DC interactions might also
be necessary for preventing overt Th2
cell responses. It has been demonstrated
that asthmatics have a reduced innate
immune response to rhinovirus infection,
a common trigger for asthma exacerba-
tion, reflected by reduced production of
type I and III interferon from bronchial
epithelial cells (Contoli et al., 2006). It
was recently shown in an in vitro study
that monocyte-derived DCs that were
differentiated in the presence of a bron-
chial epithelial cell line were instructed
to produce IL-12, IL-6, IL-10, and TNF-a,
thus promoting Th1 cell responses, away from potentially harm-
ful Th2 cell responses through epithelial-derived type I interferon
production (Rate et al., 2009). Collectively, these findings
suggest that epithelial cells modulate local DC differentiation to
optimize antimicrobial defenses in the airways and in the process
downmodulate capacity for expression of potentially damaging
Th2 cell immunity. A defective innate immune response of
epithelial cells might therefore be at the heart of allergic sensiti-
zation.
Th2 Cell Responses: Are DCs Really Redundant?
Several recent papers have demonstrated a crucial role for baso-
phils in Th2 cell immunity (Perrigoue et al., 2009; Sokol et al.,
2009; Yoshimoto et al., 2009). These papers have reinforced
the idea that basophils are an important source of IL-4 early
during an innate response to parasite infection and proteolytic
allergens like HDM or papain and at the same time also serve
as bona fide APCs that provide peptide-MHC, costimulatory416 Immunity 31, September 18, 2009 ª2009 Elsevier Inc.
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from the experimental systems in which DCs were either elimi-
nated with CD11c-DTR or antigen presentation was restricted
to CD11c-positive cells led the authors to conclude that DCs
are neither necessary nor sufficient for Th2 cell immunity. This
statement stems from a long-held paradox in DC biology that
DCs do not produce a Th2 cell-polarizing instructive cytokine,
yet can induce Th2 cell responses. This is in contrast to Th1
cell immune responses, where DCs are a well-known source of
instructive IL-12 acting downstream via STAT-4 to instruct and
stabilize Th1 cell development (Macatonia et al., 1995). For Th2
cell polarization, IL-4 was the first and foremost polarization
factor. Lung or other DCs were never found to produce IL-4,
so it was long assumed that Th2 cell development might occur
by default, when DCs were expressing peptide-MHC and costi-
mulatory molecules in the absence of polarizing IL-12 secretion
(Stumbles et al., 1998). In addition to this default pathway of Th2
cell development, others have proposed that the secretion of IL-
6 by (lung) DCs was a clear instructive signal to Th2 cell develop-
ment (Constant et al., 2002; Dodge et al., 2003; Krishnamoorthy
et al., 2008). Alternatively, cell surface instructive signals like the
Notch ligand jagged-2 (Krishnamoorthy et al., 2008), c-Kit (Krish-
namoorthy et al., 2008), and OX40L (Ito et al., 2005) were shown
to mediate DC-driven Th2 cell development.
In the field of lung immunology, several groups have shown
that either endogenous lung DCs (De Heer et al., 2004; Eisen-
barth et al., 2002; Krishnamoorthy et al., 2008; Lewkowich
et al., 2008) or adoptively transferred bone-marrow-derived
DCs (Lambrecht et al., 2000; Matsubara et al., 2006; Piggott
et al., 2005) are sufficient to induce Th2 cell responses to inhaled
antigens. This is a direct effect and not due to transfer of injected
antigen from injected DCs to resident APCs like basophils, as
shown by the fact that the injection of DCs from MHCII-deficient
mice failed to induce Th2 cell priming in a wild-type host (Kuipers
et al., 2009). This property stemsmainly from the SIRPa+CD11b+
subset of lung DCs or adoptively transferred DCs (Raymond
et al., 2009). Studies by Kim Bottomly’s group have elegantly
shown that triggering of TLR4 on lung-derived DCs by low doses
of LPS promotes Th2 cell development through a myeloid
differentiation primary-response gene 88 (MyD88)-dependent
pathway (Eisenbarth et al., 2002; Piggott et al., 2005).
There is also evidence that CD11c+ DCs are necessary for Th2
cell responses. The Th2 cell-inducing adjuvant alum is used by
manygroups to induceTh2cell sensitization to inhaledovalbumin.
However, these Th2 cell responses, as read out by induced T cell
proliferation, Th2 cell cytokine production, and IgG1 production,
were eliminated when CD11c+ DCs were depleted by diptheria
toxin treatment of CD11cDTR Tg mice (Kool et al., 2008a,
2008b). Likewise, alum-exposed DCs clearly induced Th2 cell
polarization from naive TCR Tg T cells in a process requiring cas-
pase-1 and IL-1b production (Sokolovska et al., 2007). In vitro
studies have also amply demonstrated that human DCs exposed
to allergens like the HDM Derp1 allergen (Hammad et al., 2001)
and pollen extracts (containing phytoprostanes and NADPH
oxidases) (Gilles et al., 2009) acquire Th2 cell-polarizing capacity,
even if IL-4 is not made by these exposed DCs. One report iden-
tified BDCA-3 (thrombomodulin; CD141)-positive blood DCs as
the predominant inducers of Th2 cell responses when exposed
to HDM allergen (Yerkovich et al., 2009).All these findings suggest that DCs can be sufficient and
necessary for Th2 cell immunity to allergens, at odds with the
recent reports on basophils being the only Th2 cell inducers.
The discrepancy between these studies might be in the precise
model antigen (papain as a model proteolytic allergen versus
alum-complexed antigen) or organism used, the route of admin-
istration (gut versus skin versus lung), the use of splenic DCs
versus bone-marrow DCs for comparison with basophils, and
the use of specific DC or basophil depletion strategies. All three
papers used a depleting antibody against the high-affinity IgE
receptor (MAR-1) expressed on mast cells and basophils, and
concluded that in the absence of these cells, Th2 cell immunity
failed to develop. However, in our experiments employing
10-color flow cytometry to simultaneously look at basophils
and DCs, Fc3RI is also expressed on a subset of CD11chi DCs
after allergen exposure (unpublished observations) and others
have reported this receptor similarly to be induced by virus infec-
tion on lung DCs (Grayson et al., 2007). Therefore, it is also
possible that some of the effects of ‘‘specific’’ basophil depletion
were affecting DC subsets. In our view, it also remains to be
conclusively shown whether there are sufficient basophils at
the right time and the right place to induce strong and lasting
Th2 cell immunity to inhaled allergens relevant for asthma. We
foresee a scenario by which resident lymph node basophils
collaborate with migratory DCs, providing an early source of
IL-4 to promote or sustain Th2 cell immunity (see Figure 2). In
this regard, eosinophils, mast cells, and NKT cells might be
similar innate helpers for Th2 cell immunity driven by DCs.
DCs and the Maintenance of Ongoing Allergic
Inflammation
Not only do DCs have a role in the primary immune response to
inhaled allergens, they also have a crucial role during the effector
phaseof asthma (Lambrecht andHammad, 2003). The number of
CD11b+ inflammatoryDCs is increased in theconducting airways
and lung interstitiumof sensitized andchallengedmice during the
acutephaseof the response,where they are seen to formclusters
with activated T cells, at areas of nerve endings (Beaty et al.,
2007; Veres et al., 2009). Because the chemokine receptor
CCR6 was first cloned from human lung DCs, and its ligands
CCL20 (previously known as MIP-3a) and epithelial b-defensin
are produced by airway epithelial cells (Nathan et al., 2009), it
was long assumed that CCR6 was the predominant chemoat-
tractant of immature DCs to the airways. Recent studies on
micewithmixedbone-marrowchimeras have, however, revealed
thatCCR2andnotCCR5orCCR6 is thepredominant receptor for
attracting Th2-cell-inducing DCs to the lungs of mice after
allergen exposure (Robays et al., 2007). The model is most
consistent with recruitment of CCR2+ monocytes to the lungs,
followed by rapid differentiation to monocyte-derived inflamma-
toryDCs, akin to the situationof alum-induced inflammatoryDCs.
Not surprisingly, HDM challenge leads to rapid upregulation of
the CCR2 ligand CCL-2 (MCP-1) in epithelial cells, although
also CCL20 production has been found (Hammad et al., 2009;
Nathan et al., 2009). In asthmatics, allergen challenge leads to
an accumulation of myeloid DCs and possibly pDCs in the
airways, concomitantly with a reduction in circulating CD11c+
DCs, indicating that these cells are recruited from the blood-
stream in response to allergen challenge (Jahnsen et al., 2001).Immunity 31, September 18, 2009 ª2009 Elsevier Inc. 417
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immune response is mostly supported by the fact that their
depletion at the time of allergen challenge abrogated all the char-
acteristic features of asthma, such as eosinophilic inflammation,
goblet cell metaplasia, and bronchial hyperreactivity (Lambrecht
et al., 1998; van Rijt et al., 2005). The defect was restored by the
intratracheal administration of bone-marrow-derived CD11b+
myeloid DCs, which most closely resemble the monocyte-
derived inflammatory DCs that are recruited upon allergen
challenge, and also express SIRPa involved in trafficking to the
mediastinal nodes (Raymond et al., 2009; Van Rijt et al., 2004).
In humanized SCID mice, allergen-pulsed monocyte-derived
DCs also exacerbated allergic inflammation when administered
to the lungs of sensitized mice (Hammad et al., 2002). A similar
critical role for DCs has also been found in animal models of
allergic rhinitis as well as human nasal biopsies from perennial
and seasonal allergic rhinitic patients (KleinJan et al., 2006).
Together, these experiments demonstrated that inflammatory
type DCs are necessary and sufficient for secondary Th2 cell
responses to allergen.
Function of Lung DCs in Effector Th2 Cell Responses
Afterallergenchallenge,DCsupregulate theexpressionof several
costimulatorymolecules thatmight be involved in T cell activation
or in the differentiation of regulatory T cells (Huh et al., 2003; Van
Rijt et al., 2004, 2005). Elegant experiments by Harris et al. (2002)
have demonstrated that division of memory Th2 cells occurs
mostly in the draining mediastinal nodes during allergen chal-
lenge, and this probably explains the need for a migratory APC
that takes the inhaled antigen to the nodes. Moreover, in
allergen-challengedmice, DCsmight also be themost prominent
source of the Th2-cell-attracting inflammatory chemokines
CCL17 and CCL22, acting on the chemokine receptor CCR4 to
attract Th2 cells to the lungs (see Figure 3; Beaty et al., 2007).
Two recent studies have indeed demonstrated that this is the
case. It was long known that STAT6 deficiency abrogated Th2-
cell-selective chemokine production inmousemodels of asthma.
However, the critical cellular source of STAT6-mediated chemo-
kine production had not been defined. Medoff et al. (2009)
demonstrated that STAT6 in bone-marrow-derived myeloid cells
was sufficient for the production of CCL17, CCL22, CCL11, and
CCL24 and for Th2 lymphocyte and eosinophil recruitment into
the allergic airway. In contrast, STAT6 in airway-lining cells did
not mediate chemokine production or support cellular recruit-
ment. Selective depletion of CD11b+ myeloid cells (most likely
CD11b+ inflammatory DCs) in the lung with CD11b-DTR mice
identified these cells as the critical cellular source for the chemo-
kines CCL17 and CCL22 (Medoff et al., 2009). In a second study,
we have used a humanized SCID model of asthma in which
peripheral blood mononuclear cells from HDM allergic donors
were reconstituted, followed by HDM challenge to the lungs. In
these mice, human DCs were a predominant source of CCL17
and CCL22 attracting human CCR4+ CRTH2+ Th2 cells to the
lungs of mice, excluding any contribution from epithelial chemo-
kines, because thesewereofmurine origin anddid not crossreact
with the human CCR4 (Perros et al., 2009).
The formation of allergen-specific IgE can lead to IgE-facili-
tated allergen presentation via DCs. The presence of specific
IgE bound to the high-affinity receptor for IgE (Fc3RI) on DCs
can lead to a 1000-fold lowering of the threshold for allergen418 Immunity 31, September 18, 2009 ª2009 Elsevier Inc.recognition and in this way IgE might sustain Th2 cell responses
via effects on DCs, as observed in clinical studies in which serum
IgE was neutralized with anti-IgE monoclonal antibodies (omali-
zumab) (Maurer et al., 1998). Although this mechanism has been
mainly described in human DCs, demonstration of the Fc3RI
receptor in lung DCs propose a similar mechanism in the mouse
(Grayson et al., 2007).
Many of the Th2 cell effector pathways of allergic inflammation
maintain theDCnetwork in an activated state, andoften epithelial
cells are an important intermediate cell type. Allergen challenge
or adoptive transfer of Th2 cells leads to enhanced production
of tumor necrosis factor-related apoptosis-inducing ligand
(TRAIL) in epithelial cells. Expression of TRAIL subsequently
leads to enhanced production of CCL20, in this way attracting
inflammatory CCR6+DCs and Th2 cells and perpetuating allergic
inflammation (see Figure 3; Weckmann et al., 2007). Prototypical
Th2 cytokines like IL-4 and IL-13 also feed back on the function of
the airway DCs and epithelial cells to directly or indirectly (via
DC-activating cytokines like TSLP) stimulate DCs in a STAT-
6-dependent way (Medoff et al., 2009; Miyata et al., 2009;
Webb et al., 2007). These feedback loops might be important in
understanding the chronicity of allergic inflammation.
Endogenous DAMPs Contribute to DC Activation
in Asthma
In addition to this adaptive feedback loop,DCsexpressaplethora
of receptors for endogenous DAMPs that are released at sites of
ongoing inflammation. As only a few examples, DCs express
receptors (protease-activated receptors [PARs] that are acti-
vated by proteolytic proteins like tryptase and thrombin) (Ham-
mad et al., 2001). Shortly after insult to the vascular compartment
or after pathogen entry in the mucosa, complement activation
occurs, and not surprisingly, lung DCs can sense this ‘‘acute
alert’’ through expression of the C5a and C3a anaphylatoxin
receptors (Kohl et al., 2006). They also express neuropeptide
receptors that can respond to neurotransmittors released in
response to axon reflexes or efferent neural responses, sup-
portedby the fact that lungDCssynapsewith unmyelinatednerve
endings in and beneath the airway mucosa and produce neuro-
transmittors (Veres et al., 2009). Lung DCs express receptors
for prostaglandins and these acutely released inflammatory
mediators can profoundly impact on the migration and matura-
tion of the cell (Hammad et al., 2007; Idzko et al., 2007a). Endog-
enously released metabolites like extracellular ATP trigger
purinergic receptors on lungDCsand in thisway relay information
about allergen-induced platelet aggregation or metabolic cell
stress to the cells of the immune system through widely ex-
pressed purinergic receptors (Idzko et al., 2007b; Willart and
Lambrecht, 2009). Eosinophil and mast cell degranulation can
lead to the release of eosinophil-derived neurotoxin (EDN) and
histamine that can feed back on DCs and promote further Th2
cell responses (Yang et al., 2008). Clearly, much more effort is
requiredbeforewecan fully grasp the importanceof these inflam-
matory mediators and DAMPs in explaining the chronicity of
asthma (Willart and Lambrecht, 2009).
Regulatory Lung DC Subsets
The character of the gut immune response is heavily influenced
by the continuous presence of commensal flora and continuous
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has evolved. Likewise, the lung immune response has evolved
to protect the delicate gas-exchange apparatus from overt
inflammatory reactions to inhaled harmless antigens, yet allow
induction of proper adaptive and innate immunity. It is increas-
ingly clear that again DCs have a crucial role in setting this fine
regulatory balance. Despite the fact that most inhaled antigens
are transported to the lymph node by lung-derived DCs, the
usual outcome after the inhalation of harmless protein antigen
is the induction of tolerance. When the model antigen ovalbumin
(OVA) is given into the airways of naive mice, it renders the mice
tolerant to a subsequent immunization withOVA in alum adjuvant
and effectively inhibits the development of allergic airway inflam-
mation (De Heer et al., 2004; Ostroukhova et al., 2004). This
process resembles high-dose oral tolerance and is accompa-
nied by a considerable degree of T cell division that ultimately
leads to deletional tolerance, implying that at least the antigen
is presented by lung-derived DCs to T cells in conjunction with
costimulatory molecules (Akbari et al., 2002; De Heer et al.,
2004; Vermaelen et al., 2001). Studies with FLT3L-deficient
mice have concluded that it is mainly the conducting airway
DCs (deriving from the monocytic precursors) that mediate inha-
lation tolerance (Walzer et al., 2005). Alternatively, partially
mature DCs could stimulate the induction of IL-10- and/or trans-
forming growth factor-b (TGF-b)-producing regulatory T cells
(see review by Lloyd and Hawrylowicz, 2009, in this issue), in
an IL-10 and/or inducible T cell costimulator ligand (ICOSL)-
dependent manner (Akbari et al., 2001, 2002; Ostroukhova
et al., 2004). Recently, the formation of regulatory DC subsets
was shown to be promoted by lung stromal cells that instructed
DCreg development via secretion of TGF-b (Li et al., 2008).
Once Treg cells are induced, they control respiratory immunity
by interfering with the function of resident or freshly recruited
cDCs. Mice lacking the transcription factor Runx3, involved in
downstream TGF-b signaling, spontaneously develop asthma
features. In the lungs of these mice, there is a strong increase
in the number of DCs, displaying a mature phenotype with
increased expression of MHC II, OX40-Ligand, and CCR7 (Fai-
naru et al., 2005) and demonstrating an increased immunostimu-
latory capacity. Moreover, Runx3/ DCs are able to mount
inflammatory responses to otherwise harmless inhaled antigens.
In mice normally resistant to HDM-induced asthma and BHR
(C3H mice), Treg cell depletion via the CD25-depleting Ab simi-
larly led to increased numbers of pulmonary CD11b+ DCs with
elevatedexpression ofMHCII,CD80, andCD86andan increased
capacity to stimulate Tcell proliferation andTh2cytokineproduc-
tion. In normally susceptible A-Jmice, Treg cells did not suppress
inflammation and BHR. These data suggest therefore that resis-
tance to allergen-driven BHR is mediated in part by CD4+CD25+
Treg cell suppression of DC activation and that the absence of
this regulatory pathway contributes to susceptibility (Lewkowich
et al., 2005). In a chronic model of antigen exposure in the rat,
CD4+Foxp3+ Treg cells were likewise shown to suppress BHR
via suppression of airway DC function (Strickland et al., 2006).
Plasmacytoid DCs Suppress Allergic Responses
A series of experiments have suggested that pDCs play an
important role in inhalation tolerance and homeostasis in the
respiratory tract. After inhalation of OVA, mediastinal pDCs inter-nalize OVA, but in contrast to lung-derived cDCs, they do not
present the antigen in an immunogenic manner to CD4+ T cells
(De Heer et al., 2004; Oriss et al., 2005). However, functional
evidence that these cells do influence pulmonary adaptive
immunity came from experiments in which pDCs were depleted
via antibodies. In pDC-depleted animals, inhalation tolerance
was abolished, whereas after adoptive transfer of FMS-related
tyrosine kinase 3 (FLT3L)-cultured bone-marrow-derived pDCs,
tolerance was induced (De Heer et al., 2004). Similarly, the Th2
cell-like immunopathology induced by respiratory syncitial virus
was exacerbated when pDCs were depleted (Smit et al., 2006).
Comparative phenotypic and functional analysis of pulmonary
DC populations in mice susceptible (A-J) or resistant (C3H) to
experimental asthma revealed that susceptibility to BHR is
associated with preferential CD11b+ cDC allergen uptake and
production of Th17 cell-skewing cytokines (IL-6, IL-23), whereas
resistance is associated with increased allergen uptake by pDCs
(Lewkowich et al., 2008).
Both in vitro and in vivo studies have clearly shown that pDCs
stimulate the induction of regulatory T cells, possibly in an
ICOSL-dependent manner (De Heer et al., 2004; Ito et al.,
2007). Once induced, regulatory T cells could also induce the
production of the tryptophan catabolizing enzyme indoleamine
2,3-dioxygenase (IDO) through reverse signaling in pDCs (Groh-
mann et al., 2007). However, this scenario is less likely in the lung
because IDO is mainly involved in promoting Th2 cell immunity
by DCs in the lung (Xu et al., 2008). Recently, several studies
have more carefully studied how pDCs mediate anti-inflamma-
tory effects in the lung. The anaphylatoxin C5a has been previ-
ously implicated in protection from allergic sensitization in the
lungs, by setting the balance in favor of pDCs over cDCs (Kohl
et al., 2006). In a follow-up study by the same group, C5aR
targeting regulated the frequency of pulmonary plasmacytoid
DCs expressing costimulatory molecules B7-H1 and B7-DC.
Ex vivo blockade of B7-H1 (PD-L1) and B7-DC (PD-L2)
increased Th2 cytokine production from T cells of wild-type
but not of C5aR-targeted mice, suggesting a protective role for
C5a through regulation of B7 molecule expression on plasmacy-
toid DCs (Zhang et al., 2009). Along the same lines, adoptive
transfer of cultured pDCs to lungs of mice, or in vivo expansion
of these cells through Flt3L administration suppressed the
salient features of asthma when given during secondary chal-
lenge. Adoptive transfer of PD-L1-deficient (Cd274/) pDCs
failed to transfer this regulatory effect, whereas transfer of
Ido1/, Icosl/ pDCs readily did, even in the presence of
blocking IFNa antibodies (Kool et al., 2009). It therefore seems
that PD-L1 has a predominant effect in dampening lung immune
responses by pDCs, although it remains to be established how
this affects possible Treg cell induction. The cytokine osteopon-
tin is produced in higher amounts in the airways of asthmatics
compared with nonasthmatic controls. It is most likely that os-
teopontin promotes Th2 cell sensitization by altering the balance
between the numbers of tolerogenic and immunogenic lung-
derived DCs, although the mechanism involved remains unclear
at present (Xanthou et al., 2007).
Lung DCs and IgA Responses
Secretory IgA is a crucial component of first-line immune mech-
anisms at mucosal surfaces and has many anti-inflammatoryImmunity 31, September 18, 2009 ª2009 Elsevier Inc. 419
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have been shown to be imprinted in Peyer’s patches by DCs
that program B cells to class switch to IgA synthesis. Peyer’s
patch DCs program B cells to class switch to IgA synthesis
and home to the lamina propria of the gut via TGF-b and retinoic
acid metabolites (Mora et al., 2006). Although there is only
preliminary evidence for an involvement of retinoic acid in lung
immune responses (Goswami et al., 2009), lung DCswere shown
to promote IgA switching in B cells in a TGF-b-dependent
manner (Naito et al., 2008). By employing the mucosal adjuvant
cholera toxin B (CTB) subunit to the lungs, we were able to
induce IgA responses to coadministered OVA antigen via effects
on lung DCs. Adoptive transfer of CTB-exposed DCs induced
IgA responses that dampened allergic inflammation and BHR,
in a process dependent on secreted IgA, because all protective
effects were abolished in the Pigr/ mice, that cannot secrete
IgA or IgM into their epithelial lumina (Smits et al., 2009). The
expression of PIGR is under the control of Th2 cytokines, leuko-
triens, and allergen challenge, so this is a pathway of immuno-
regulation in the lung that clearly deserves more study.
Dendritic Cell Targeting to Treat Allergic Disease
If DCs are so crucial in mounting and maintaining immune
responses to inhaled allergen, then interfering with their function
could constitute a novel form of treatment for allergic diseases. A
strategy to eliminate DCs from the airways is probably not
a viable option, because local depletion of airway DCs was
recently shown to lead to severe exacerbation of respiratory
virus infection like influenza, whereby the virus failed to be
cleared from the lungs and led to severe systemic illness (Geurts-
vanKessel et al., 2008). Therefore, we are favoring the idea of tar-
geting the fine-tuning mechanisms whereby DCs maintain
allergic inflammation. Recently, several unique molecules have
been identified thatmay alter DC function in allergic inflammation
and therefore could be possible therapeutic targets. Many of
these compounds were first discovered by their potential to
interfere with DC-driven Th2 cell sensitization. The sphingosine
1-phosphate receptor antagonist FTY720 is currently used in
clinical trials for multiple sclerosis and transplant rejection.
When given locally in the lungs of mice with established inflam-
mation, it strongly reduced inflammation by suppressing the
T cell stimulatory capacity and migratory behavior of lung DCs,
without the commonly observed lymphopaenia when the drug
is given orally (Idzko et al., 2006). FTY720 inhibited the potential
of DCs to form stable synapses with naive antigen-specific
T cells as well as effector Th2 cells, providing a possible expla-
nation as to how these drugsmight work to inhibit allergic inflam-
mation. The drugable spleen tyrosine kinase (Syk) pathway has
been shown to be crucial for Th2 cell induction by airway DCs
(Barrett et al., 2009; Krishnamoorthy et al., 2008; Matsubara
et al., 2006), and downstreamof this pathway, the signaling inter-
mediate PI3Kd might similarly be a good drug target.
The number and activation status of lung CD11b+ DCs during
secondary challenge seems crucial for controlling allergic
inflammation, so studying the factors that control recruitment,
survival, or egress of DCs from the lung during allergic inflam-
mation will be important, because this might reveal new thera-
peutic targets (Robays et al., 2007). Eicosanoid lipid mediators
such as prostaglandins and leukotrienes can also influence420 Immunity 31, September 18, 2009 ª2009 Elsevier Inc.the migration of lung DCs (Hammad et al., 2007). Selective
agonists of particular receptors for members of the prosta-
glandin family might also suppress DC function. Prostaglandin
D2 has pleiotropic effects in the immune system, because of
its activity on the DP1 and CRTH2 (also known as DP2) recep-
tors, which are widely expressed on immune cells. The DP1
agonist BW245C strongly suppressed the spontaneous migra-
tion of lung DCs to the mediastinal lymph node (Hammad
et al., 2003a). More importantly, BW245C suppressed airway
inflammation and bronchial hyperreactivity when given to
allergic mice by inhibiting the maturation of lung DCs. More
detailed information on the interactions between DCs, epithelial
cells, basophils, and other inflammatory cells will undoubtedly
lead to the discovery of more potentially interesting drugs. In
this regard, blocking the interaction of TSLP and GM-CSF
with its respective receptor with small-molecule inhibitors or
blocking antibodies might prove very useful. Downstream of
these, blockade of CCR4 or its ligands might prevent DC-driven
recruitment of Th2 cells.
Disease Modification
Stimulation of the immunoregulatory properties of DCs might
reset the balance of the allergic immune response in favor of
the development of regulatory T cells and could lead to a more
long-lasting effect on the natural course of allergic disease.
One way of achieving this would be by using a combination of
steroids and vitamin D analogs, both compounds impacting on
DC function and stimulating Treg cell differentation (see review
by Lloyd and Hawrylowicz, 2009, this issue). Steroids are
currently the cornerstone of anti-inflammatory treatment in
allergic disease. Inhaled steroids reduce (but do not eliminate)
the number and modulate the function of DCs in the lungs and
nose of patients with allergic asthma and allergic rhinitis (Ham-
mad and Lambrecht, 2006). Steroids also induce the activation
of the IDO enzyme in pDCs in a glucocorticoid-induced TNF-
receptor-related protein ligand (GITRL)-dependent way, thereby
broadly suppressing inflammatory responses (Grohmann et al.,
2007). Prostaglandins or their metabolites might have the same
effect. In the presence of the DP1 agonist BW245C, DCs induced
the formation of induced forkhead box P3 (FOXP3)+ regulatory
T cells from FOXP3 antigen-specific T cells, in a process
requiring cAMP and protein kinase A (Hammad et al., 2007). A
very similar mechanism was described for inhaled iloprost,
a prostacyclin analog that acts on the I prostanoid (IP) receptor
expressed by lung DCs (Idzko et al., 2007a; Zhou et al., 2007).
Downstream metabolites of prostaglandins include agonists of
the PPARg family. Pharmacological PPARg agonists like the
antidiabetic drug rosiglitazone were able tomodify lung DC func-
tion and stimulate the formation of IL-10-producing T cells, thus
suppressing features of asthma (Hammad et al., 2004). Finally,
the stimulation of the IgA-inducing capacities of lung DCs might
be an appropriate strategy that could have prolonged effects in
allergic disease, akin to the effects of desensitization immuno-
therapy (Smits et al., 2009).
Concluding Remarks
Epidemiological studies on the risk factors and genetics of
asthma, as well as mouse models of the disease, have revealed
a crucial interplay between airway epithelial cells and DCs. In
Immunity
Reviewa reductionist view, the reason why certain antigens are ‘‘aller-
gens’’ and the reason why the exposure to certain environmental
factors promote Th2 cell responses can almost all be brought
back to a fundamental interference with the way the antigen is
sampled by airway DCs across the epithelial barrier or the way
some allergens are able to activate epithelial cells or directly acti-
vate DCs. In the future it will be important to study in greater
detail how genetic polymorphisms regulating epithelial barrier
function and epithelial and DC activation promote allergic sensi-
tization.
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